Clear Acne Face Cleanser

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the treatment of acne. It is intended for use in patients diagnosed with acne vulgaris, providing therapeutic benefits to manage and reduce the severity of this condition.

Dosage and Administration

The affected area should be covered with a thin layer of the product, applied 1 to 3 times daily. It is recommended to start with one application per day to minimize the risk of excessive drying of the skin. If tolerated, the frequency may be gradually increased to two or three times daily, as needed or as directed by a healthcare professional.

For optimal use of the cleanser, the face should be wet prior to application. The cleanser should be applied to the hands, followed by the addition of water to create a lather. This lather should be gently massaged over the entire face, taking care to avoid the eye area. After massaging, the face should be rinsed thoroughly and patted dry. This cleanser is suitable for daily use.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the frequency of application to once daily or every other day. For children under 10 years of age, consultation with a healthcare professional is recommended prior to use.

Contraindications

Use of this product is contraindicated in the following situations:

• Do not use if irritation persists.

• Avoid contact with the eyes; in case of contact, rinse eyes thoroughly with water.

• Concurrent use with other topical acne medications is contraindicated unless directed by a healthcare professional.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to avoid ingestion of the product. In the event of accidental swallowing, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult their healthcare provider if any irritation persists. Continuous monitoring of the patient's response to the treatment is recommended to ensure safety and efficacy.

Side Effects

Patients should be advised that the product is for external use only. In the event that irritation persists, it is recommended that they stop using the product and consult a healthcare professional.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately after the application of this product. In such cases, it is advisable to limit the use to one medication at a time unless otherwise directed by a healthcare professional. Monitoring for signs of excessive dryness or irritation is recommended to ensure patient comfort and treatment efficacy.

Packaging & NDC

Below are the non-prescription pack sizes of Clear Acne Face Cleanser (acne face cleanser). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 10 years of age should be evaluated by a healthcare professional prior to use. It is essential to consult a doctor to determine the appropriateness of treatment and any necessary dosage adjustments for this age group.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no specific information regarding the use of this product in pregnant patients. The prescribing information does not indicate whether the product is contraindicated during pregnancy or outline any associated risks to the fetus. Additionally, there are no dosage modifications or special precautions recommended for use during pregnancy. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the clinical scenario and the substance involved. Consultation with a poison control center or a medical toxicologist is recommended for guidance on the appropriate management strategies.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose to mitigate potential complications and ensure patient safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should discontinue use and consult a doctor if irritation persists.

Patients should be cautioned to avoid contact with the eyes. In the event of accidental eye contact, they should rinse their eyes thoroughly with water.

Additionally, healthcare providers should discuss the potential for increased dryness or irritation of the skin when using this product in conjunction with other topical acne medications. Patients should be instructed to use only one medication at a time unless otherwise directed by a healthcare professional.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from direct light exposure to protect its quality. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the medication is topical. Clinicians are advised to consult a doctor for patients who are children under 10 years of age. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Clear Acne Face Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)